News

The FDA has escalated Alma Pak International LLC's organic blueberry recall to a Class I, the most severe classification, ...
A recall was announced after bacteria were found that could cause serious adverse health consequences or death.
A new FDA alert has classified and updated a recent blueberry recall as a Class I health risk, the agency’s most serious ...
The FDA has granted accelerated approval to linvoseltamab-gcpt (Lynozyfic) for the treatment of adult patients with ...
The FDA has approved Takeda’s new immunoglobulin therapy, Gammagard liquid ERC [immune globulin infusion (human)], to treat ...
Takeda Pharmaceuticals said the Food and Drug Administration approved its liquid Gammagard immunoglobulin treatment. The drugmaker said Monday that commercialization of Gammagard Liquid is expected to ...
They’re a summer flavor favorite, and this is the first time we've seen a recall specifically for this controversial reason.